furosemide has been researched along with vancomycin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (22.22) | 29.6817 |
| 2010's | 15 (55.56) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Carbon, C; Contrepois, A; Cremieux, AC; Nivoche, Y | 1 |
| Mirahmadi, MK; Vaziri, ND | 1 |
| Baraldo, M; Furlanut, M; Pea, F; Porreca, L | 1 |
| Cheung, PY; Etches, PC; Peliowski, A; Robertson, CM; Tyebkhan, JM | 1 |
| Abazia, DT; Marcus, A; Ross, J; Sachinwalla, E; Smolarz, BG | 1 |
| Baranowska, I; Baranowski, J; Wilczek, A | 1 |
| Deveikis, A; Hernandez, E; Jahng, M; Le, J; McKamy, S; Moriwaki, T | 1 |
| Arcinue, R; Elkhwad, M; Kantak, A | 1 |
| Gruneir, A; Howard, AW; Koren, G; Parshuram, CS; Rochon, PA; Slater, MB | 1 |
| Almashanu, S; Bier Palmon, R; Eventov-Friedman, S; Flidel-Rimon, O; Golan, A; Kats, N; Keidar, R; Marom, R; Troitzky, M; Zung, A | 1 |
| Effraim, P; Li, L; Tham, SW; Waxman, S | 1 |
| Fuchigami, Y; Hagimori, M; Hata, K; Kawakami, S; Makizoe, T; Miura, Y; Munakata, C; Sasahara, S; Sasaki, H; Tachiki, H; Yamaoka, M | 1 |
| Costa, TXD; Leopoldino, RWD; Martins, RR; Nascimento, ARFD; Santos, METD | 1 |
| Al Ansari, E; Al Jufairi, M; Al Madhoob, A; Al Marzooq, R; Al Segai, O; Hashem Ahmed, H; Husain Shaban, G; Malalla, Z; Saeed Tabbara, K; Sridharan, K | 1 |
| Bitner-Glindzicz, M; Chant, K; Marlow, N | 1 |
| Cedile, J; Dano, C; Gras, E; Jean, A; Jouclas, D; Kassis Chikhani, N; Katsahian, S; Le Guen, J; Lebeaux, D; Manar, D; Patas D'illiers, C; Rocher, V; Tran, Y | 1 |
1 review(s) available for furosemide and vancomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for furosemide and vancomycin
| Article | Year |
|---|---|
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Topics: Anti-Bacterial Agents; Bayes Theorem; Cardiac Surgical Procedures; Cardiotonic Agents; Cardiovascular Agents; Creatinine; Critical Care; Diuretics; Dobutamine; Dopamine; Drug Interactions; Female; Furosemide; Hemodynamics; Humans; Intensive Care Units; Male; Middle Aged; Postoperative Care; Retrospective Studies; Vancomycin | 2000 |
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
Topics: Amikacin; Aminoglycosides; Anti-Infective Agents; Audiometry, Pure-Tone; Auditory Threshold; Diuretics; Ethacrynic Acid; Female; Furosemide; Gentamicins; Hearing Loss, Sensorineural; Humans; Infant, Newborn; Male; Pancuronium; Respiratory Insufficiency; Severity of Illness Index; Tobramycin; Vancomycin; Vecuronium Bromide | 2006 |
24 other study(ies) available for furosemide and vancomycin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
Topics: Animals; Diffusion; Drug Interactions; Female; Furosemide; Kinetics; Protein Binding; Rabbits; Time Factors; Vancomycin | 1982 |
Hearing loss in end-stage renal disease - effect of dialysis.
Topics: Furosemide; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Renal Dialysis; Vancomycin | 1980 |
Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
Topics: Acetamides; Acetaminophen; Analgesics; Anti-Infective Agents; Cellulitis; Diphenhydramine; Drug Combinations; Famotidine; Furosemide; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Oxycodone; Pulmonary Edema; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Rapid UHPLC method for simultaneous determination of vancomycin, terbinafine, spironolactone, furosemide and their metabolites: application to human plasma and urine.
Topics: Blood Chemical Analysis; Calibration; Chromatography, High Pressure Liquid; Furosemide; Humans; Naphthalenes; Reproducibility of Results; Spironolactone; Terbinafine; Time Factors; Urinalysis; Vancomycin | 2010 |
Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children.
Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Biomarkers; California; Child; Child, Preschool; Creatinine; Diuretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furosemide; Humans; Incidence; Infant; Infant, Newborn; Logistic Models; Male; Microbial Sensitivity Tests; Multivariate Analysis; Retrospective Studies; Risk Factors; Vancomycin; Young Adult | 2011 |
Acute kidney injury in ELBW infants (< 750 grams) and its associated risk factors.
Topics: Abruptio Placentae; Acute Kidney Injury; Adult; Amphotericin B; Anti-Bacterial Agents; Case-Control Studies; Cefotaxime; Clindamycin; Creatinine; Diuretics; Ductus Arteriosus, Patent; Enterocolitis, Necrotizing; Female; Furosemide; Humans; Hydrochlorothiazide; Infant, Extremely Low Birth Weight; Infant, Newborn; Infections; Intracranial Hemorrhages; Ohio; Parenteral Nutrition, Total; Pregnancy; Prevalence; Respiration, Artificial; Retrospective Studies; Risk Factors; Steroids; Survival Rate; Time Factors; Uterine Hemorrhage; Vancomycin; Young Adult | 2015 |
Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
Topics: Acute Kidney Injury; Adolescent; Case-Control Studies; Child; Child, Preschool; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Female; Furosemide; Gentamicins; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Retrospective Studies; Risk Factors; Vancomycin | 2017 |
Risk Factors for the Development of Delayed TSH Elevation in Neonatal Intensive Care Unit Newborns.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Cefotaxime; Cesarean Section; Diuretics; Dopamine; Ductus Arteriosus, Patent; Erythrocyte Transfusion; Female; Fluconazole; Furosemide; Humans; Hypoglycemic Agents; Hypothyroidism; Ibuprofen; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Insulin; Intensive Care Units, Neonatal; Male; Multivariate Analysis; Neonatal Screening; Pneumothorax; Respiration, Artificial; Retrospective Studies; Risk Factors; Sympathomimetics; Thyrotropin; Time Factors; Vancomycin | 2017 |
Between fire and ice: refractory hypothermia and warmth-induced pain in inherited erythromelalgia.
Topics: Anti-Bacterial Agents; Child; Cold Temperature; Erythromelalgia; Female; Furosemide; Hot Temperature; Humans; Hypothermia; Mutation, Missense; NAV1.7 Voltage-Gated Sodium Channel; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyethylene Glycols; Rewarming; Skin Diseases, Vesiculobullous; Sodium Potassium Chloride Symporter Inhibitors; Surface-Active Agents; Thyroxine; Treatment Outcome; Vancomycin | 2017 |
[Effect of pH and Additives on the Compatibility between Vancomycin and Furosemide Injections].
Topics: Anti-Bacterial Agents; Chemical Phenomena; Crystallization; Drug Combinations; Drug Interactions; Drugs, Generic; Furosemide; Hydrogen-Ion Concentration; Injections; Magnetic Resonance Spectroscopy; Mass Spectrometry; Time Factors; Vancomycin | 2018 |
DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE.
Topics: Anti-Bacterial Agents; Brazil; Cross-Sectional Studies; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Heart Diseases; Hospitalization; Hospitals, Teaching; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Pharmacists; Pharmacy Service, Hospital; Prospective Studies; Safety; Treatment Outcome; Vancomycin | 2020 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A Virus Cellular Receptor 1; Humans; Ibuprofen; Infant, Newborn; Kidney Diseases; Lipocalin-2; Male; Middle Aged; Vancomycin | 2021 |
Cumulative risk factors contributing to hearing loss in preterm infants.
Topics: Case-Control Studies; Child; Deafness; Furosemide; Gentamicins; Hearing Loss; Humans; Infant; Infant, Newborn; Infant, Premature; Risk Factors; Vancomycin | 2023 |
Incidence of and risk factors for local complications of peripheral venous catheters in patients older than 70 years: Empirical research quantitative.
Topics: Aged; Aged, 80 and over; Catheter-Related Infections; Catheterization, Central Venous; Catheterization, Peripheral; Catheters, Indwelling; Empirical Research; Female; Furosemide; Humans; Incidence; Male; Prospective Studies; Risk Factors; Vancomycin | 2023 |